APAC Whole Slide Imaging Market

APAC Whole Slide Imaging Market Size (2022 to 2027)

The size of the whole slide imaging market in the APAC region was valued at USD 114.22 million in 2022, growing at a CAGR of 23.45% from 2022 to 2027 and USD 327.43 million by 2027.

The key factors driving the APAC WSI market are increased usage in drug discovery processes, technological advancements in whole slide imaging, and the growing popularity of virtual slides in research and development. With the increase in research, many pharmaceutical and biotechnology companies have made significant investments in drug discovery. Therefore, imaging and image-based technologies are now mainstream in the drug discovery workflow and hold great promise, enabling researchers to understand and work with model organisms. Additionally, factors such as growing demand for new treatment options, reduction in laboratory expenses, and better patient care facilities will support the market.

Additionally, the use of whole slide imaging to study blood coagulation disorders and the increasing number of hematopoietic neoplasms is expected to drive the growth of the overall market. WSI helps improve the standardization, quality, and manageability of research and helps reduce costs. Thereby, development in WSI is expected to impact market growth directly. For instance, Digital Pathology (DP) is generating a lot of interest among hospitals, laboratories, research institutes, and biotechnology companies. DP is also expected to increase productivity and efficiency by allowing pathologists to communicate with each other easily.

Whole slide imaging devices are increasingly used for precision medicine and many diseases with digital technology, which is likely to be a key factor in improving patient care. Furthermore, with advances in digital pathology and computer-aided artificial intelligence technology, digital health is inevitably grabbing awareness from international and local companies, which will increase the growth prospects in this market. Moreover, developing regions have enormous potential for the growth of key players due to untapped opportunities in the Asia-Pacific region.

On the contrary, the acceptance of scanned images in clinical validation studies by regulatory authorities remains a challenge affecting the market growth. Also, the high cost of purchasing and maintaining WSI systems, scarcity of defined professional billing codes, and lack of standardization of whole slide imaging may have a negative impact on the APAC whole slide imaging market during the studied period.

This research report on the APAC whole slide imaging market has been segmented and sub-segmented into the following categories:

By Product:

• Scanners
• Viewers
• Image management system
• Software
• Service
• Hardware

By Application:

• Telepathology
• Cytopathology
• Immunohistochemistry
• Hematopathology
• Cancer
• Cardiology

By End-User:

• Biotechnology and Pharmaceutical Companies
• Academic and Research Institutes
• Hospitals and Clinics

By Country:

• India
• China
• Japan
• South Korea
• Australia
• New Zealand
• Thailand
• Malaysia
• Vietnam
• Philippines
• Indonesia
• Singapore
• Rest of APAC

The regional market in China is expected to be witnessing the highest CAGR during the aforementioned forecast period. Several factors such as the increase in drug discovery research, the presence of a large population base, rapidly growing chronic disease prevalence, and awareness of the benefits of WSI.

Other countries such as Australia, India, and South Korea are expected to experience a promising CAGR by 2027. Various factors such as support of government initiatives to utilize advanced technologies, the popularity of medical tourism, the strong presence of prominent players, and increased research and development activities will help the regional markets.

The Japanese market is projected to generate significant revenue between 2022 and 2027 owing to the growing advancements in the healthcare sector, growing population prone to various diseases, the significant increase in the number of drug discovery activities, excellent patient care facilities, and increased investment in R&D due to increased consumer awareness.

KEY MARKET PLAYERS:

Philips, Siemens, Positron Corporation, Agfa-Gevaert N.V., CardiArc Ltd., Digirad Corporation, Gamma Medica Inc., GE Healthcare, Hologic Inc., Leica Microsystems GmbH, Nikon Corporation, Visiopharm, 3Dhistech, Hamamatsu Photonics KK, and Indica Labs are a few of the companies playing a key role in the APAC whole slide imaging market profiled in this report.